ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #3,554Hybrid

Stem Cell Reviews and Reports

Acronym:stcr
•
Abbreviation (ISO):STEM CELL REV
•
Identifier (ISSN):1550-8943(Print)/2629-3277(Online)
•
Publisher:Springer US
Former Names:
STEM CELL REV REP
Clarivate JCR Index Advisory: Name Changed (Active in JCR)
Clarivate IF (2026)
4.9↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Stem Cell Reviews and Reports

WoS Q2
24793.6120184.720195.3220205.7420216.6920224.820234.520244.220254.92026
Annual Impact Factor Metric
Current (2026):4.9
Scopus SJR & RankScopus Q2
1.217
#3,554

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
96

96 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate4.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
178articles/year
38.68% Gold OA•89.22% Original Research

Aims & Scope

The purpose of Stem Cell Reviews and Reports is to cover contemporary and emerging areas in stem cell research and regenerative medicine. The journal will consider for publication: i) solicited or unsolicited reviews of topical areas of stem cell biology that highlight, critique and synthesize recent important findings in the field. ii) full length and short reports presenting original experimental work. iii) translational stem cell studies describing results of clinical trials using stem cells as therapeutics. iv) papers focused on diseases of stem cells. v) hypothesis and commentary articles as opinion-based pieces in which authors can propose a new theory, interpretation of a controversial area in stem cell biology, or a stem cell biology question or paradigm. These articles contain more speculation than reviews, but they should be based on solid rationale. vi) protocols as peer-reviewed procedures that provide step-by-step descriptions, outlined in sufficient detail, so that both experts and novices can apply them to their own research. vii) letters to the editor and correspondence. In order to facilitate this exchange of scientific information and exciting novel ideas, the journal has created five thematic sections, focusing on: i) the role of adult stem cells in tissue regeneration; ii) progress in research on induced pluripotent stem cells, embryonic stem cells and mechanism governing embryogenesis and tissue development; iii) the role of microenvironment and extracellular microvesicles in directing the fate of stem cells; iv) mechanisms of stem cell trafficking, stem cell mobilization and homing with special emphasis on hematopoiesis; v) the role of stem cells in aging processes and cancerogenesis.

Topics Covered (Recognized by AI)
Biology98.9%Genetics98%Cell biology95.2%Stem cell89.4%Chemistry86%Biochemistry85%Medicine78.1%Gene67.3%Internal medicine59.7%Pathology47.3%Embryonic stem cell46.4%In vitro36.7%Cell35.2%Cellular differentiation34.6%Immunology34.5%Mesenchymal stem cell28.7%Induced pluripotent stem cell25.7%Cancer research24.3%Endothelial stem cell22.7%Surgery21.8%Psychology21.7%Endocrinology21.6%Progenitor cell21.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL & TISSUE ENGINEERING

Q2
Rank11/32
IndexSCIE
JCRSCIE2026

CELL BIOLOGY

Q2
Rank78/207
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank52/191
IndexSCIE
JCISCIE2026

CELL & TISSUE ENGINEERING

Q2
Rank9/32
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q2
Rank70/207
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank56/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

19 year
2026Latest
IF4.9
Articles / Year—
Total Citations—
2025
IF4.2
Articles / Year—
Total Citations—
2024
IF4.5
Articles / Year—
Total Citations—
2023
IF4.8
Articles / Year—
Total Citations—
2022
IF6.692
Articles / Year—
Total Citations—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,554Scopus Q2SCImago Profile
Scopus Coverage:2009-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology
Scopus Citation Rank (SJR)Q2
1.217

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
4.47

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,418 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,754
3-Year Documents550
Citable Documents514

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate47.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ2
Cell BiologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Stem Cell Reviews and Reports (acronym: stcr, abbr: STEM CELL REV, ISSN: 1550-8943) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 2005. The periodical holds a Journal Impact Factor (JIF) of 4.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.217 (Q2), an H-index of 96.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 178 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,418 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
Quarterly
Founding Year
2005
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER HEIDELBERG, TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-69121

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 83a8f79e-a770-45aa-be58-28b824909d04
Database Updated: 2026-10-01